MAPT and Alzheimer disease: Previous studies have shown that natural products exhibited biological activities against AD by inhibiting cyclin-dependent kinase 5 and tau phosphorylation and reducing Aβ42 and Aβ40 production toward the nonamyloidogenic pathway [13,14].